Variant acute promyelocytic leukaemia with novel NAB2::RARA fusion shows clinical all-trans retinoic acid and arsenic trioxide sensitivity
Details
Publication Year 2023-08,Volume 202,Issue #4,Page 893-896
Journal Title
British Journal of Haematology
Publication Type
Case report
Publisher
Wiley
Keywords
Humans; Arsenic Trioxide/therapeutic use; *Leukemia, Promyelocytic, Acute/drug therapy/genetics; Tretinoin/pharmacology/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Oxides/pharmacology/therapeutic use; Oncogene Proteins, Fusion/genetics; *Arsenicals/therapeutic use; Retinoic Acid Receptor alpha; Repressor Proteins
Department(s)
Clinical Haematology; Pathology
PubMed ID
37280781
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-11-08 07:27:52
Last Modified: 2024-07-16 04:00:46

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙